⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19335682 | 0.74 | — | — | |
| SCHEMBL12015992 | 0.74 | — | — | |
| SCHEMBL1333020 | 0.74 | — | — | |
| SCHEMBL2733921 | 0.74 | — | — | |
| SCHEMBL6415635 | 0.74 | — | — | |
| SCHEMBL23701031 | 0.70 | — | — | |
| SCHEMBL15669080 | 0.70 | — | — | |
| SCHEMBL30310752 | 0.70 | — | — | |
| SCHEMBL19066686 | 0.70 | — | — | |
| SCHEMBL28915510 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2510036-A2 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | Promerus LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011072304-A2 | NORBORNENE-TYPE POLYMERS HAVING QUATERNARY AMMONIUM FUNCTIONALITY | PROMERUS LLC (US) | 2011-06-16 | — | — | WO | disclosed |
| US-20080275025-A1 | Substituted Lactams and Their Use as Anti-Cancer Agents | NOVARTIS AG | 2008-11-06 | — | — | US | disclosed |
| US-7378410-B2 | Substituted lactams and their use as anti-cancer agents | NOVARTIS AG (CH) | 2008-05-27 | — | — | US | disclosed |
| EP-1282604-B1 | SUBSTITUTED CAPROLACTAM CARBONATES AND ETHERS AND THEIR USE AS ANTI-TUMOR AGENTS | NOVARTIS AG (CH) | 2008-01-09 | — | — | EP | disclosed |
| US-20060281731-A1 | Substituted lactams and their use as anti-cancer agents | BAIR, KENNETH WALTER | 2006-12-14 | — | — | US | disclosed |
| EP-1651633-A1 | SUBSTITUTED LACTAMS AND THEIR USE AS ANTI-CANCER AGENTS | Novartis AG (CH) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005014574-A1 | SUBSTITUTED LACTAMS AND THEIR USE AS ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | disclosed |
| EP-1131297-B1 | CERTAIN SUBSTITUTED CAPROLACTAMS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN TREATING TUMORS | NOVARTIS AG (CH) | 2004-04-14 | — | — | EP | disclosed |
| US-6599898-B2 | Selected from the group consisting of breast, lung, non-small cell lung, osteolytic, colon and prostate | NOVARTIS AG (CH) | 2003-07-29 | — | — | US | disclosed |
| US-6555533-B2 | Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas | NOVARTIS AG (CH) | 2003-04-29 | — | — | US | disclosed |
| US-20030055041-A1 | Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors | KINDER FREDERICK RAY (US) | 2003-03-20 | — | — | US | disclosed |
| EP-1282604-A1 | SUBSTITUTED CAPROLACTAM CARBONATES AND ETHERS AND THEIR USE AS ANTI-TUMOR AGENTS | Novartis AG (CH) | 2003-02-12 | — | — | EP | disclosed |
| US-6413954-B1 | 3,4,5-TRIHYDROXY-2-METHOXY-8,8-DIMETHYL-N-((3,6)-HEXAHYDRO-2 -OXO-6-(((DECYLOXY)CARBONYL)OXY)-2H-AZEPIN-3-YL)NON-6-ENON-AMIDES; SYNTHESIS BY ACYLATION AND HYDROLYSIS; HIGHER SELECTIVITY IN KILLING CANCER CELLS; CHEMOTHERAPY | NOVARTIS AG (CH) | 2002-07-02 | — | — | US | disclosed |
| US-20010044433-A1 | Use of certain substituted caprolactams in treating tumors | NOVARTIS AG (CH) | 2001-11-22 | — | — | US | disclosed |
| WO-2001085697-A1 | SUBSTITUTED CAPROLACTAM CARBONATES AND ETHERS AND THEIR USE AS ANTI-TUMOR AGENTS | NOVARTIS AG (CH) | 2001-11-15 | — | — | WO | disclosed |
| EP-1131297-A1 | CERTAIN SUBSTITUTED CAPROLACTAMS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN TREATING TUMORS | Novartis AG (CH) | 2001-09-12 | — | — | EP | disclosed |
| US-6239127-B1 | CHEMOTHERAPY OF TUMORS, EXHIBIT A HIGH DEGREE OF SELECTIVITY IN KILLING CANCER CELLS. | NOVARTIS AG (CH) | 2001-05-29 | — | — | US | disclosed |
| WO-2000029382-A1 | CERTAIN SUBSTITUTED CAPROLACTAMS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN TREATING TUMORS | NOVARTIS AG (CH) | 2000-05-25 | — | — | WO | disclosed |